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ABSTRACT
Growth Factor Independent-1B (Gﬁ-1B) is a transcrip-
tional repressor that plays critical roles in the control of
erythropoiesis and megakaryopoiesis. Gﬁ-1B expression
was described to be repressed by an autoregulatory feed-
back control loop. Here, we show that Gﬁ-1 transcription
is positively regulated early after induction of erythroid
differentiation and remains highly active to late erythro-
blasts. Using chromatin immunoprecipitation assays in
CD34
1 cells from human cord blood, we found that Gﬁ-1
and GATA-2 in immature progenitors and then Gﬁ-1B
and GATA-1 in erythroblasts are bound to the Gﬁ-1B pro-
moter as well as to the promoter of c-myc, a known Gﬁ-
1B target gene. Surprisingly, this Gﬁ-1/GATA-2–Gﬁ-1B/
GATA-1 switch observed at erythroblast stages is associ-
ated to an increase in the Gﬁ-1B transcription whereas it
triggers repression of c-myc transcription. Accordingly,
analysis of chromatin modiﬁcation patterns shows that
HDAC, CoREST, and LSD1 are recruited to the c-myc
promoter leading to appearance of repressive chromatin
marks. In contrast, the Gﬁ-1B promoter remains associ-
ated with a transcriptionally active chromatin conﬁgura-
tion as highlighted by an increase in histone H3
acetylation and concomitant release of the LSD1 and CoR-
EST corepressors. The repressive function of Gﬁ-1B there-
fore depends on the nature of the proteins recruited to the
target gene promoters and on chromatin modiﬁcations.
We conclude that Gﬁ-1B behaves as a lineage-afﬁliated
gene with an open chromatin conﬁguration in multipotent
progenitors and sustained activation as cells progress
throughout erythroid differentiation. STEM CELLS
2009;27:2153–2162
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INTRODUCTION
The adult hematopoietic system consists of multiple distinct
blood cell lineages and is continuously regenerated from he-
matopoietic stem cells. How cell fate is chosen and maintained
during differentiation processes remains elusive. Increasing
evidence indicates that coordinated activation of characteristic
sets of genes and the silencing of others play an important role
in these processes [1]. Recent studies have demonstrated that
epigenetic modiﬁcations regulate the chromatin state of genes
and then their potential to be transcribed. Furthermore, tran-
scription factors can assemble into highly dynamic complexes.
In hematopoietic cells, GATA proteins are part of different ac-
tivator and repressor complexes. A complex between GATA-1
and Gﬁ-1B was identiﬁed on c-myb and c-myc loci in ery-
throid cells [2]. These two genes encode for proteins involved
in cell proliferation; their repression is requested for the arrest
of the cell cycle and the initiation of erythroid differentiation.
Gﬁ-1 and Gﬁ-1B are members of the Gﬁ zinc-ﬁnger tran-
scriptional repressor family, whose structure is characterized
by an N-terminal repressor domain called SNAG and six C-
terminal C2H2 zinc ﬁngers [3]. Gﬁ-1 and Gﬁ-1B are differen-
tially expressed in hematopoietic cells. Gﬁ-1 is expressed in
immature progenitors and highly expressed in granulocytes [4,
5], whereas Gﬁ-1B expression in differentiated cells is re-
stricted to erythroid and megakaryocytic cells [6, 7]. Analysis
of Gﬁ-1B:green ﬂuorescent protein knockin mice has shown
that Gﬁ-1B expression is dynamically regulated during murine
erythropoiesis [6]. Deletion of the Gﬁ-1 gene in mouse pro-
vokes a severe disturbance of hematopoietic stem cell func-
tion due to excessive cycling and severe neutropenia [4, 8, 9].
Gﬁ-1B-deﬁcient mice are not viable beyond embryonic day
14.5 and fail to produce deﬁnitive enucleated red cells [10].
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strongly disturbs erythroid maturation [7, 11]. Gﬁ-1 and Gﬁ-
1B bind to the same consensus DNA sequence TAAAT
CAC(A/T)GCA [3, 12, 13]. Knockin mice in which the Gﬁ-1
coding region was replaced by Gﬁ-1B showed that Gﬁ-1B can
replace Gﬁ-1 in the regulation of hematopoiesis [14].
The mechanisms accounting for the Gﬁ-1B transcriptional
regulation are not fully understood. The Gﬁ-1B promoter was
cloned and an erythroid-speciﬁc promoter region was charac-
terized in K562 cells. Interestingly, while transcriptional activa-
tion of the Gﬁ-1B gene relies mainly on GATA proteins, its
repression was proposed to be under an autoregulatory feedback
loop in NIH3T3 or K562 cells [15, 16]. Chromatin regulatory
proteins (LSD1, CoREST, and HDAC) have been suggested to
mediate transcriptional repression of Gﬁ-1B by Gﬁ-1B [17]. Evi-
dences for this autoregulation pathway come from studies in
NIH3T3 or undifferentiated K562 cells overexpressing Gﬁ-1B,
as well as in MEL or in the spleen and thymus of vav-Gﬁ-1B
transgenic mice [18]. This observation is in contradiction with
the high levels of Gﬁ-1B expression observed at the various
stages of erythroid differentiation, suggesting that active mecha-
nisms may impede Gﬁ-1B from repressing its own transcription
in differentiating erythroid cells.
We herein study the mechanisms accounting for dynamic
regulation of Gﬁ-1B expression in human multipotent progenitors
induced to differentiate toward erythroid lineage. We show that
the Gﬁ-1B promoter remains associated with transcriptionally
active chromatin modiﬁcations during erythroid differentiation
despite of the binding of Gﬁ-1B. Furthermore, as undifferentiated
progenitors acquire morphological features of erythroblasts, an
increase in the acetylation of histone H3 and a release of the co-
repressors, CoREST and LSD1, are observed at the Gﬁ-1B pro-
moter. By contrast, CoREST and LSD1 are recruited together
with Gﬁ-1B at the promoter of a Gﬁ-1B target gene, c-myc,l e a d -
ing to its silencing. Our results thus show that binding of Gﬁ-1B
to its own promoter does not lead to its silencing during ery-
throid differentiation due release of corepressors.
MATERIALS AND METHODS
Cell Cultures
Human UT-7 5.3 cells (a clone of UT-7 cells [19]) were main-
tained in a-MEM supplemented with 10% heat-inactivated fetal
calf serum (FCS), 2 mM L-glutamine, and 5 ng/mL of granulo-
cyte-macrophage colony-stimulating factor. UT-7 5.3 cells were
induced to differentiate by addition of 2 U/mL of erythropoietin
(EPO); cells synthesizing hemoglobin were detected by benzidine
staining. Human K562 cells were maintained in Dulbecco’s modi-
ﬁed Eagle’s medium supplemented with 10% heat-inactivated
FCS and 2 mM L-glutamine. K562 cells were induced to differ-
entiate by addition of 0.1 lM of cytosine arabinoside (AraC).
Human umbilical cord blood samples were collected from normal
full-term deliveries, after informed consent of the mothers accord-
ing to the approved institutional guidelines of AP-HP (Paris). Af-
ter isolation of mononuclear cells by density gradient separation,
CD34
þ cells were puriﬁed using magnetic bead separation (Stem
Cell Technologies, Vancouver, BC, Canada, http://www.stemcell.
com). CD34
þ cells (purity  95%) were used immediately or after
storage in liquid nitrogen. CD34
þ cells were maintained for
5 days in serum-free Stem Span medium (Stem Cell Technologies)
supplemented with 25 ng/mL of stem cell factor (SCF), 10 ng/mL
of interleukin-3 (IL-3), 10
-6 M of dexamethasone, and 2 U/mL of
EPO. Then, cells were induced to differentiate during 5–6 days in
Stem Span medium supplemented with 25 ng/mL of SCF and 2 U/
mL of EPO. Recombinant human EPO was a gift from Dr.
M. Brandt (Roche Diagnostics, Basel, Switzerland, http://www.
roche-applied-science.com). Others cytokines were purchased from
Promocell Bioscience Alive (Heidelberg, Germany, http://www.
promocell.com).
Cell Transduction
UT-7 5.3 cells were infected with a lentiviral vector carrying a
Gﬁ-1B-speciﬁc shRNA, with a sequence previously described
[11]. At 48 hours after infection, nuclear proteins and mRNAs
were prepared.
Polymerase Chain Reaction
Oligo(dT)-primed cDNA were synthesized from total RNAs using
the superscript II reverse transcriptase (Invitrogen, Carlsbad, CA,
http://www.invitrogen.com). Then 2 lL of cDNA were then
ampliﬁed with Taq polymerase using the following thermal cy-
cling program: 95 C for 5 minutes, 40 cycles of 5 seconds at
95 C, 5 seconds at 60 C, and 10 seconds at 72 C, followed by a
5-minute extension time at 72 C. The primer sequences used
were as follows: Gﬁ-1B:5 0-CAGCACTGAGCCCGCCTTG
GACTT-30 (sense), 50-GTGGGTGGACAGCGTGGACGAGCG-30
(antisense), GAPDH:5 0-TGGGATTTCCATTGATGACAA-30
(sense), 50-CCACCCATGGCAAATTCC-30 (antisense) and c-myc
50-ATGAAAAGGCCCCCAAGGTAGTTAT-30 (sense), 50-GCA
TTTGATCATGCATTTGAAACAA-30 (antisense).
Preparation of Nuclear Extracts and
Oligonucleotide Pulldown
For nuclear extract preparation, cells were washed once with
phosphate-buffered saline (PBS) and incubated for 10 minutes at
4 C in buffer A (10 mM HEPES, pH 7.6, 3 mM MgCl2,1 0m M
KCl, 5% glycerol, 0.5% NP-40) containing 1 mM Na2VO4,
20 mM NaF, 1 mM sodium pyrophosphate, 25 mM b-glycero-
phosphate and proteinase inhibitors (Roche). After centrifugation,
nuclear pellets were resuspended in buffer A containing 300 mM
KCl. For oligonucleotide pulldown assays, complexes from 10
7
cell nuclear extracts were precipitated by addition of 1, 2, or
4 lg double-strand biotin-labeled oligonucleotide at 4 C for 1
hour. DNA-protein complexes were then pelleted using streptavi-
din-agarose beads (Amersham Biosciences, Piscataway, NJ,
http://www.gelifesciences.com). Beads were then washed three
times with buffer A and resuspended in 1  Laemmli buffer. The
biotinylated oligonucleotides used were: Core Gﬁ-1B 50 [Biot]–
GACACAAATAATCAGATTGAAAATCAGGGAG–30, Core
Gﬁ-1B mutated 50 [Biot]–GACACAAATGGTCAGACC-
GAAGGTCAGGGAG–30, Gﬁ-1B consensus 50 [Biot]–TGCA-
CAGTAAATCACTGCATTGCGGA–30, Gﬁ-1B consensus
mutated 50 [Biot]–TGCACAGTAGGTCACTGCATTGCGGA–30,
GATA consensus 50 [Biot]–GCCTGGGTAGAGATAAGTGCCTG
GC–30, GATA consensus mutated 50 [Biot]–GCCTGGGTAGA-
GACCAGTGCCTGGC–30, c-myc oligo 50 [Biot]–GGAAGG-
TATCCAATCCAGATAGCTGTGCA–30, c-myc oligo mutated 50
[Biot]–GGAAGGGGTCCGGTCCAGACCGCTGTGCA–30.
Western Blot Analysis and Antibodies
Samples were subjected to 10% SDS-polyacrylamide gel electro-
phoresis and transferred to nitrocellulose membrane (Schleicher
and Schuell). Filters were blocked overnight in 5% skimmed milk
Tris-buffered saline (TBS) 0.05% Tween 20 and incubated with
the appropriate antibody. Membranes were washed four times in
TBS-Tween 20 and incubated for 1 hour with the appropriate per-
oxidase-conjugated secondary antibody. The primary antibodies
used were as follows: Gﬁ-1 N20 (sc-8558, Santa Cruz Biotech-
nology Inc., Santa Cruz, CA, http://www.scbt.com), GATA-2
H116 (Santa Cruz Biotechnology, sc-9008), GATA-1 N1 (Santa
Cruz Biotechnology, sc-266), c-Myc C-33 (Santa Cruz Biotech-
nology, sc-42), LSD1 (ab-17721, Abcam, Cambridge, U.K.,
http://www.abcam.com), CoREST (07-455, Upstate, Charlottes-
ville, VA, http://www.upstate.com), and b-actin (A5441, Sigma-
Genosys, Cambridge, U.K., http://www.sigmaaldrich.com). Serum
against Gﬁ-1B was prepared in the laboratory. Brieﬂy, the Gﬁ-1B
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to the Glutathion-S-Transferase and produced in bacteria. Super-
natant was puriﬁed on glutathion-sepharose and injected into rab-
bits. The serum was used as polyclonal antibody. The HorseRad-
ish Peroxydase-conjugated secondary antibodies were as follows:
anti-rat (Santa Cruz, sc-2006), anti-rabbit (7074, Cell Signaling
Technology, Beverly, MA, http://www.cellsignal.com), anti-goat
(6165, SouthernBiotech, Birmingham, AL, http://www.southern-
biotech.com), and anti-mouse (7076, Cell Signaling Technology).
Chromatin Immunoprecipitation Assays
Cells were ﬁxed with 1% formaldehyde for 10 minutes at room
temperature before termination with 0.125 M glycine. Cells were
then lysed in chromatin immunoprecipitation (ChIP) buffer (1%
SDS, 10 mM EDTA, and 50 mM Tris-HCl, pH 8.1) and cross-
linked chromatin was sonicated to obtain DNA fragments of
300–800 bp. Immunoprecipitations were performed following the
Upstate protocol (www.upstate.com). Antibodies used were as
follows: GATA-1 C20 (Santa Cruz, sc-1233), Ac Lys9/14-H3
(Upstate, 06-599), di-methyl Lys4-H3 (Upstate, 07-030), di-
methyl Lys9-H3 (Abcam, ab-1220), tri-methyl Lys9-H3 (Upstate,
07-523), HDAC1 clone 2E10 (Upstate, 05-100). Antibodies
against Gﬁ-1B, Gﬁ-1, GATA-2, LSD1, and CoREST used for
ChIP assays were the same as for Western blot. The correspond-
ing normal rabbit, goat, or mouse immunoglobulins G (IgG, Santa
Cruz) were used as control. The immunoprecipitated DNA was
used for polymerase chain reaction (PCR) with the following
thermal cycling program: 95 C for 5 minutes, 40 cycles of 30
seconds at 95 C, 30 seconds at 60 C, and 45 seconds at 72 C,
followed by a 5-minute extension time at 72 C. The Gﬁ1B pro-
moter sequence was ampliﬁed with the primers 50-GAATTC
GAAGTCTTGTGTCC-30 (sense) and 50-GTGTGTTTTTCCTCT
TCTGT-30 (antisense), the c-Myc promoter with the primers
50-GAAGGTATCCAATCCAGATAGCTGTGC-30 (sense) and 50-
GAGCGTGGGATGTTAGTGTAGATAGGG-30 (antisense), the
Pax6 enhancer with the primers 50-GTCCGGTGCCTTGA
ACCAT-30 (sense) and 50-GCGCAACTACCGCCTCTAAA-30
(antisense), and the Gﬁ-1 promoter with the primers 50-TCTTG
GCTCCAGGGAGAC-30 (sense) and 50-GGAGGGTCCTCGGA
GC-30 (antisense). The primers 50-CCAGTCTAGTGCATGCCTT
CTTAA-30 (sense) and 50-CAAGCCAGCGACGCAGT-30 (anti-
sense) amplify the b2microglobulin promoter as control.
RESULTS
Gﬁ-1B Gene Expression Is Upregulated at the
Transcriptional Level During Human Erythroid
Differentiation
We ﬁrst studied the kinetics of Gﬁ-1B mRNA and protein
expression during in vitro erythroid differentiation of human
CD34 positive cells (CD34
þ). CD34
þ cells were isolated
from cord blood and cells were ampliﬁed in a two-phase cul-
ture system: a 5-day ampliﬁcation step (D1–D5) in the pres-
ence of SCF, IL-3, EPO, and dexamethasone followed by a 5-
day differentiation step (E0–E5) in the presence of SCF and
EPO. May-Grunwald-Giemsa (MGG) staining and cytoﬂuor-
ometry analysis demonstrated that the cells remained imma-
ture (CD34 positive with no phenotypical changes or morpho-
logical features, Fig. 1A and data not shown) during the
ampliﬁcation step (D0 to D5–E0). The expanded cells started
to acquire morphologic features of proerythroblasts 2 days af-
ter the beginning of the second phase of the culture (E2) and
of erythroblasts 3–5 days later (Fig. 1A). During the ampliﬁ-
cation phase, the expression of Gﬁ-1B was low at both
mRNA and protein levels (Fig. 1B, 1C). Two days after
induction of erythroid differentiation (E2), when the cells
acquired proerythroblast features, Gﬁ-1B mRNA level
increased 2.5-fold, whereas Gﬁ-1B protein level increased
fourfold. Then a small additional increase in Gﬁ-1B mRNA
and protein levels occurred between days 3 and 4; Gﬁ-1B
expression remained high until E5. We then analyzed the ki-
netic of expression of erythroid transcription factors known to
bind the erythroid speciﬁc Gﬁ-1B promoter in K562 cells [15,
16]. It appeared that GATA-1 expression was similar to that
of Gﬁ-1B, with GATA-1 being barely expressed in immature
CD34
þ progenitors and highly expressed in differentiated
cells. GATA-2 and Gﬁ-1 proteins were expressed at high lev-
els in CD34
þ cells (E0). Their expression decreased early af-
ter induction of erythroid differentiation when the cells ac-
quire morphological features of proerythroblasts (E1 and E2;
Fig. 1C). Thus, Gﬁ-1B expression increased when cells
acquired erythroid features (E2) and was highly expressed at
the end of human erythroid differentiation.
Binding of GATA-1 and Gﬁ-1B to the Gﬁ-1B
Promoter Increases During Human
Erythroid Differentiation
To determine when GATA-1, GATA-2, Gﬁ-1, and Gﬁ-1B
bind to the Gﬁ-1B promoter, ChIP experiments were per-
formed before and after induction of erythroid differentiation
using speciﬁc antibodies. Immunoprecipitated DNAs were
ampliﬁed by quantitative real-time PCR with primers surround-
ing the binding sites of Gﬁ and GATA sites (-163 to
-14) at the Gﬁ-1B promoter (supporting information Fig. 1A).
In immature progenitors (D2 and E0), GATA-2 and Gﬁ-1 were
recruited at the Gﬁ-1B promoter (fold increases of 4.2 and 2.3,
respectively), whereas GATA-1 and Gﬁ-1B were absent. When
the cells acquired erythroid features (E3), a decreased recruit-
ment of GATA-2 and Gﬁ-1 and an increased recruitment of
GATA-1 (fold increase 6.0) and Gﬁ-1B (fold increase 4.4) on
the Gﬁ-1B promoter were observed (Fig. 2). GATA-1 and Gﬁ-
1B recruitment was maximal when cells were differentiated
(fold increase 7 and 8, respectively, at E5). As control, qualita-
tive PCR was performed with primers located upstream of the
Gﬁ-1B promoter on the same immunoprecipitated materials and
no speciﬁc enrichment was observed. Thus, we conclude that,
throughout the erythroid differentiation, the binding of the ery-
throid transcription factors at the Gﬁ-1B promoter correlate
with their expression pattern.
Gﬁ-1/GATA-2, Gﬁ-1B/GATA-1 Switch Also Occurs
at the C-Myc Promoter
To investigate why Gﬁ-1B binding to its own promoter at the
erythroblast stages does not lead to its transcriptional repres-
sion, we analyzed the binding of GATA and Gﬁ proteins at
the c-myc promoter, which has been described as a Gﬁ-1B
target gene in MEL cells [2]. In a ﬁrst step, we conﬁrmed
that c-myc expression was downregulated during erythroid
differentiation from human CD34
þ progenitors (Fig. 3A), as
already described in MEL cells [20] and K562 [21]. Then, we
analyzed whether c-myc transcriptional repression was de-
pendent on Gﬁ-1B protein. Using lentiviruses transducing
shRNA against Gﬁ-1B, we showed that downregulation of
Gﬁ-1B in undifferentiated cells led to an increase in the c-
myc mRNA and protein levels (Fig. 3B, 3C), suggesting that
Gﬁ-1B plays a role in the repression of c-myc transcription.
To analyze the dynamics of GATA and Gﬁ binding at the c-
myc promoter, ChIP experiments were performed before
(CD34
þ cells, E0) and after induction of erythroid differentia-
tion (E3–E5) with the same antibodies as in Figure 2B. Quali-
tative PCR was performed with primers speciﬁc of c-myc pro-
moter (supporting information Fig. 1B) or b2-microglobulin
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tion, GATA-2 and Gﬁ-1 were recruited to the c-myc promoter
(2-fold increase), GATA-1 was poorly recruited and Gﬁ-1B
was absent. Then, the recruitment of GATA-2 and Gﬁ-1
decreased and the recruitment of GATA-1 and Gﬁ-1B
increased at the c-myc promoter, 3 and 4 days after induction
of erythroid differentiation. Thus, as observed for the Gﬁ-1B
promoter, the exchange of GATA-2/Gﬁ-1 for GATA-1/Gﬁ-1B
occurs at the c-myc promoter during the erythroid differentia-
tion. However, more importantly, at the end of differentiation
(E5) when c-myc was no more transcribed, GATA-1 and Gﬁ-
1B were no more found at the c-myc promoter (Fig. 3D),
whereas GATA-1 and Gﬁ-1B remained highly bound at the
Gﬁ-1B promoter (Fig. 2). Thus, a similar switch between
GATA-2/Gﬁ-1 and GATA-1/ Gﬁ-1B occurs at the Gﬁ-1B and
c-myc promoters but an important difference is observed at
the end of differentiation (E5): the GATA-1/Gﬁ-1B complex
is released from c-myc promoter, whereas it is maintained at
the Gﬁ-1B promoter.
Gﬁ-1B Promoter Remains Associated with
Active Chromatin Marks Throughout
Erythroid Differentiation
To investigate further the chromatin status at the Gﬁ-1B pro-
moter, during erythroid differentiation, we analyzed the his-
tone post-translational modiﬁcations. Histone H3 acetylation
on K9 and K14 and/or dimethylation on K4 correlate with
transcriptional activation, whereas methylation on K9 is
linked to transcriptional repression. The histone post-transla-
tional modiﬁcations at the Gﬁ-1B promoter were compared
with those of c-myc promoter by ChIP assays. Cross-linked
chromatin from CD34
þ undifferentiated (E0) or differentiated
(E3 and E5) cells was immunoprecipitated with antibodies
speciﬁc for histone H3 acetylated on lysine 9 and 14 (H3K9/
14ac), histone H3 dimethylated on K4 (H3K4me2), or histone
H3 dimethylated on lysine 9 (H3K9me2). Promoters of genes
transcribed (b2-microglobulin) or silent (Gﬁ-1 and Pax6)i n
erythroid cells were used as controls. Interestingly, the Gﬁ-1B
promoter exhibited active chromatin marks such as acetylation
on K9/K14 (H3-K9/14ac) and methylation on K4 of histone
H3 (H3-K4me2) in immature progenitor cells and these marks
gradually increased during erythroid differentiation (from E0
to E5). Furthermore, the Gﬁ-1B promoter carried no repres-
sive chromatin marks (di-methylation on K9 of histone H3)
throughout erythroid differentiation.
Concerning the c-myc promoter, the histone modiﬁcation
patterns evolved differently throughout erythroid differentia-
tion. Active chromatin marks (H3-K9/14ac and H3-K4me2)
were present at the c-myc promoter in immature progenitors,
but these marks decreased during differentiation (E5; Fig. 4).
Moreover, the dimethylation on K9 of histone H3, low at E0,
was evident at E5 of differentiation at the c-myc promoter.
The b2-microglobulin promoter showed transcriptionally
Figure 1. Gﬁ-1B expression increases after induction of erythroid differentiation and remains elevated along erythroid development. CD34-posi-
tive cells were puriﬁed from cord blood samples and cultured in a two-phase system. During the ﬁrst phase of 5 days (D1–D5), CD34
þ cells
were cultured in the presence of interleukin-3, stem cell factor (SCF), erythropoietin (EPO), and dexamethasone. Then, the cells were induced to
differentiate in the presence of EPO and SCF (E0–E5). (A): Cytology of the cells. Cytospin samples were prepared every day and stained with
May-Grunwald-Giemsa. Different subpopulations were characterized under the microscope and the proportion of each subpopulation was eval-
uated. (B): Gﬁ-1B mRNA expression during erythropoiesis. mRNAs were prepared from CD34
þ cells before (D2 and D5) and every day after
induction of erythroid differentiation (E0–E5). Reverse-transcription polymerase chain reaction was performed using Gﬁ-1B-speciﬁc primers.
Data are expressed as the ratio between Gﬁ-1B and GAPDH mRNA. (C): Cell lysates were prepared from the same cell populations as in (B).
Total cell extracts were analyzed by SDS-polyacrylamide gel electrophoresis (PAGE) and Western blotting using a Gﬁ-1B speciﬁc antibody. The
membrane was stripped and re-hybridized with Gﬁ-1-, GATA-2- and GATA-1-speciﬁc antibodies. Actin was detected by a speciﬁc antibody to
conﬁrm equal protein loading. These results are representative of three experiments with different samples.
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K4 of H3) and no repressive marks (no methylation on
H3K9). On the contrary, the Gﬁ-1 promoter and the Pax6
enhancer were associated with repressive histone modiﬁca-
tions (no acetylation on K9 or K14, nor methylation on K4
and K9 of histone H3) during the whole process of erythroid
differentiation. Thus, our results showed that the Gﬁ-1B pro-
moter remains associated with a combination of active histone
modiﬁcations, whereas the c-myc promoter was associated
with negative marks at the end of human erythroid differentia-
tion. These data suggest strongly that the Gﬁ-1B promoter,
but not the c-myc promoter, stays in a transcriptionally active
state throughout erythroid differentiation.
CoREST and LSD1 Repressors Are Released
from the Gﬁ-1B Promoter During Human
Erythroid Differentiation
Gﬁ-1 and Gﬁ-1B have been reported to recruit histone-modi-
fying enzymes, HDAC, LSD1, and CoREST, through their
SNAG domain at their target gene promoters [17]. These
cofactors are considered to act as corepressors of transcrip-
tion. HDAC-1 is a histone deacetylase and LSD1 is a lysine-
speciﬁc demethylase (demethylating K4 of histone H3).
CoREST interacts with LSD1 and positively regulates LSD1
function [22]. To determine whether changes in chromatin
structure at the Gﬁ-1B or c-myc promoters were associated
with changes in the recruitment of these enzymes, we ana-
lyzed HDAC, LSD1, and CoREST binding in vivo at the Gﬁ-
1B, c-myc, and b2-microglobulin promoters during erythroid
differentiation. HDAC1 was not found at the Gﬁ-1B promoter
(Fig. 5), which agrees with the increased histone acetylation
at the Gﬁ-1B promoter during erythroid development (Fig. 4).
Furthermore, LSD1 and CoREST were initially found associ-
ated at the Gﬁ-1B promoter before induction of erythroid dif-
ferentiation and were released from the Gﬁ-1B promoter dur-
ing erythroid differentiation. By contrast, HDAC1, LSD1 and
CoREST are found at the c-myc promoter at E3 and E4, when
c-myc transcription decreased until complete silencing at E5.
The binding of this complex at the c-myc promoter would be
induced speciﬁcally by Gﬁ-1B, as described by others on Gﬁ-
1B target gene promoters [17]. Thus, LSD1 and CoREST
cofactors are present at the Gﬁ-1B promoter in CD34
þ pro-
genitors (E0) but are released at erythroblast stages as histo-
nes H3 are hyperacetylated.
LSD1 and CoREST Bind to c-myc but Not to
Gﬁ-1B Oligonucleotides
To determine whether the promoter sequence has a role in the
recruitment of activating or repressing cofactors, we carried
out in vitro DNA afﬁnity precipitation experiments with nu-
clear extracts from UT-7 5.3 cells. Indeed, during EPO-
induced erythroid differentiation of these cells, GATA and
Gﬁ factors exhibited a similar expression pattern as during
the EPO-induced differentiation of CD34
þ cells (Fig. 6A). As
a ﬁrst step, we veriﬁed that we could get the same results by
this in vitro technique as by in vivo chromatin immunopreci-
pitation experiments. Biotinylated oligonucleotides containing
the three consensus Gﬁ-1/Gﬁ-1B-binding sites (Gﬁ-1B core)
of the Gﬁ-1B promoter were incubated with nuclear extracts
from UT-7 5.3 cells before (E0) and after (E5) induction of
erythroid differentiation. Before EPO stimulation, GATA-2
and Gﬁ-1 proteins bound to the Gﬁ-1B core. Consistent with
their expression dropping at later stages of differentiation, the
binding of GATA-2 and Gﬁ-1 decreased in differentiated UT-
7 5.3 cells. Conversely, the binding of GATA-1 and Gﬁ-1B
was low at E0 and was elevated on the Gﬁ-1B core oligonu-
cleotides at late stages of erythroid differentiation (Fig. 6B,
E0.1 and E5.1). GATA and Gﬁ factors did not bind to the oli-
gonucleotides when the three Gﬁ-1/Gﬁ-1B binding sites were
mutated (Fig. 6B, E0.2 and E5.2). Thus, these results are
consistent with in vivo data: (1) a switch between a GATA-2/
Gﬁ-1 and a GATA-1/Gﬁ-1B occupancy and (2) a sustained
binding of GATA-1 and Gﬁ-1B at late stages of erythroid dif-
ferentiation. These results also conﬁrm that GATA proteins,
GATA-2 then GATA-1 throughout the erythroid differentia-
tion, bind at the consensus Gﬁ-1/ Gﬁ-1B binding sites.
Thus, because GATA-1 and Gﬁ-1B associate with the Gﬁ-
1B core oligonucleotides in vitro, similar oligo pulldown
experiments can be carried out to compare molecules bound
at the Gﬁ-1B or the c-myc promoters. Nuclear extracts from
Figure 2. GATA-2 and Gﬁ-1 and then GATA-1 and Gﬁ-1B bind at
the Gﬁ-1B promoter during erythropoiesis induced from CD34-posi-
tive cells. Chromatin immunoprecipitation (ChIP) analyses were per-
formed on CD34
þ cells (D2 or E0) and 3 or 5 days after induction of
erythroid differentiation (E3 and E5) with GATA-2-, GATA-1-, Gﬁ-
1- and Gﬁ-1B-speciﬁc antibodies. Qualitative polymerase chain reac-
tion was performed with two pairs of primers, one that ampliﬁes a
sequence located upstream to the Gﬁ-1B promoter (-2.3kb) and the
other one that ampliﬁes the Gﬁ-1B promoter (-0.15 kb). Results are
expressed as enrichment values (bound/input) relative to immunopre-
cipitate with IgG antibody and are means   SD of three independent
ChIP experiments (except for the D2 that has been performed only
once because of the small number of cells).
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entiation were incubated with increasing amount of biotinyl-
ated oligonucleotides representing either the Gﬁ-1B (Gﬁ-1B
core) or the c-myc promoters. The results showed that, at the
end of differentiation, a higher amount of Gﬁ-1B was bound
to the Gﬁ-1B core than to the c-myc oligonucleotides,
Figure 3. GATA-2 and Gﬁ-1 then GATA-1 and Gﬁ-1B bind to c-myc promoter during erythroid differentiation. (A): The c-myc expression in
CD34
þ cells that are induced to differentiate in the presence of erythropoietin (EPO) and stem cell factor. Cells were harvested and lysed the ﬁrst
day (E0) and then every day (E1–E5) after induction of erythroid differentiation by EPO. Total cell extracts were analyzed by SDS-polyacryl-
amide gel electrophoresis and Western blotting using Gﬁ-1B-, c-myc- or actin-speciﬁc antibodies. (B, C): The c-myc accumulation at the mRNA
(C) and protein (B) levels after of Gﬁ-1B depletion. UT-7 cells were infected with a lentiviral vector carrying a Gﬁ-1B-specifc shRNA. At 48
hours after infection, nuclear proteins were harvested and mRNAs were prepared. Proteins were analyzed by Western blot with c-myc-, Gﬁ-1B-,
and actin-speciﬁc antibodies. RNAs were reverse transcribed and ampliﬁed with primers speciﬁc of c-myc or GAPDH, and the ratio c-myc/
GAPDH was calculated. (D): Chromatin immunoprecipitation analysis using chromatin from CD34
þ cells (E0) or from cells harvested 3, 4, or 5
days after induction of erythroid differentiation (E3, E4, and E5) were performed with antibodies against GATA-2, GATA-1, Gﬁ-1, Gﬁ-1B, and
IgG control. Qualitative polymerase chain reaction was performed using primers amplifying the c-myc or the b2-microglobulin promoter regions.
Results are expressed as enrichment values (bound/input) relative to immunoprecipitate with IgG antibody and are means   SD of three experi-
ments for each antibody. *, p < .03, **, p < .008
2158 Gﬁ-1B Stays Active upon Erythroid Differentiationwhereas GATA-1 bound equivalently to the two oligonucleo-
tides. Thus, the LSD1 and CoREST recruitment at the Gﬁ-1B
or c-myc promoters is independent of the presence of Gﬁ-1B
but depends on the precise promoter sequence. These in vitro
data are consistent with the in vivo data and suggest that the
presence of Gﬁ-1B at the Gﬁ-1B promoter is not sufﬁcient to
maintain the binding of LSD1 and CoREST at the end of the
erythroid differentiation.
DISCUSSION
Gﬁ-1B-deﬁcient mice fail to produce deﬁnitive enucleated red
blood cells [10], suggesting that the maturation of erythroid pre-
cursor cells into deﬁnitive erythrocytes is dependent on the pres-
ence of Gﬁ-1B. Thus, Gﬁ-1B transcription must be sustained dur-
ing erythroid differentiation. This is not consistent with Gﬁ-1B
expressionbeingrepressedbyanautoregulatoryfeedbackcontrol
loop, as has beensuggested for NIH3T3 or K562cells [15]. Here,
we show that Gﬁ-1Bdoesnotrepress its owntranscription during
erythroid differentiation of human primary CD34
þ cells. Indeed,
the present data show that Gﬁ-1B expression is maintained at
high levels throughout erythroid differentiation in spite of Gﬁ-1B
binding to its own promoter. Luciferase experiments also show
thattheGﬁ-1Bpromoterstaysactivewhentransfectedintodiffer-
entiatederythroidcells(datanotshown).
Using ChIP assays, we have shown that the transcription
of Gﬁ-1B is dynamically controlled during human erythroid
differentiation. Before commitment towards the erythroid line-
age (i.e., at the immature progenitor stages), Gﬁ-1B is barely
expressed and GATA-2 and Gﬁ-1 are bound to its promoter.
At the erythroblast stages, GATA-2/Gﬁ-1 are replaced by
GATA-1/Gﬁ-1B; this switch is associated with an increase in
Gﬁ-1B transcription. These results raise the following ques-
tion: Why is the switch between GATA-2/Gﬁ-1 and GATA-1/
Gﬁ-1B at the Gﬁ-1B promoter associated with an increase in
Gﬁ-1B transcription? In agreement with results reported by
Huang et al. [15], we observed that GATA-2 is a less power-
ful transcriptional activator than GATA-1 (data not shown).
This result may explain why Gﬁ-1B expression is lower in
immature progenitor cells than in differentiated erythroid
cells. It has also been proposed that, upon cell maturation,
GATA-1 and GATA-2 do not have the same function. For
example, GATA-1 displaces GATA-2 at the Kit promoter
leading to reconﬁguration of chromatin organization and mod-
iﬁcation of Kit transcription [23].
Although in overexpression experiments Gﬁ-1B is able to
repress its own transcription (supporting information Fig. 3A,
[16]), our results show that while endogenous Gﬁ-1B together
with GATA-1 are found at the Gﬁ-1B promoter during
erythroid differentiation, no repression of GATA-mediated
Gﬁ-1B transcription is observed. This suggests that the role of
Gﬁ-1B depends on the promoter context. Accordingly, we
Figure 4. Gﬁ-1B locus
remains permissive for tran-
scription while c-myc promoter
is silenced in late erythroblasts.
Chromatin immunoprecipitation
(ChIP) assays using chromatin
from CD34
þ cells harvested the
day of induction of erythroid
differentiation (E0) and 3 or 5
days later (E3 and E5) were
performed with antibodies
against acetyl histone H3 (H3-
K9/14Ac), antidimethyl histone
H3K4 (H3K4me2), antidimethyl
H3K9 (H3K9me2), and IgG.
Qualitative polymerase chain
reaction was performed with
primers speciﬁc of Gﬁ-1B, c-
myc, Gﬁ-1, and b2-microglobu-
lin promoters or Pax6 enhancer.
Results are shown as enrichment
values (bound/input) relative to
results with IgG antibody and
are means   SD of 2–5 inde-
pendent ChIP experiments. ***,
p < .004, **, p < .03, *, p <
.08.
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erythroblast stages. Gﬁ-1B binds to the proximal c-myc pro-
moter and the depletion of Gﬁ-1B by shGﬁ-1B in erythroid
cells leads to an increase of c-myc mRNA expression, thus
demonstrating that c-myc silencing does indeed rely on Gﬁ-
1B repressor activity. Therefore, Gﬁ-1B acts or not as a tran-
scriptional repressor in erythroid cells. It has been suggested
that Gﬁ-1B can exert its repressor activity by interacting with
GATA-1 and converting GATA-1-mediated activation to
repression at the promoters of Gﬁ-1B and Bcl-xL [16, 24] in
NIH3T3 cotransfected with GATA-1 and Gﬁ-1B. However,
our results show that, during erythroid differentiation, endoge-
nous Gﬁ-1B and GATA-1 are bound together at both the Gﬁ-
1B and the c-myc promoters but this binding leads, in one
case, to transcriptional activation and, in the other case, to
transcriptional repression.
Furthermore, DNA binding precipitation assays showed
that the absence of GATA-1 binding does not impede Gﬁ-1B
recruitment and, vice versa, the absence of Gﬁ-1B binding
does not prevent GATA-1 recruitment at the Gﬁ-1B promoter
(supporting information Fig. 2). This provides evidence that
Gﬁ-1B does not need GATA-1 to bind DNA. Our results
therefore indicate that GATA-1 and Gﬁ-1B interaction on a
promoter is not sufﬁcient to induce transcriptional repression.
The difference in the function of Gﬁ-1B at c-myc and Gﬁ-1B
promoters may rather result from the difference in the pro-
moter sequence itself as demonstrated by oligo pulldown
experiments. Indeed, at the Gﬁ-1B promoter the ‘‘Gﬁ-1B
core’’ contains three putative Gﬁ-1/Gﬁ-1B binding sites that
bind both Gﬁ and GATA proteins, while the proximal c-myc
promoter contains two GATA and one Gﬁ-1/Gﬁ-1B binding
sites. This difference could lead to different afﬁnity of GATA
and Gﬁ proteins for the Gﬁ-1B and the c-myc promoter
sequences; the amount of bound factors may be responsible
for recruitment or stability of cofactor complexes at these
sites and thereby to different transcriptional activities.
Figure 5. Corepressors are dif-
ferently recruited at the Gﬁ-1B
or at c-myc promoters. Chroma-
tin immunoprecipitation analysis
with chromatin from CD34
þ
cells harvested the day of the
induction of erythroid differen-
tiation (E0) and 3, 4, or 5 days
later (E3, E4, and E5) with anti-
bodies against HDAC-1, LSD-1,
Co-Rest, and IgG as control.
Qualitative polymerase chain
reaction were performed with
primers speciﬁc of Gﬁ-1B, c-
myc, or the b2-microglobulin
promoters. Results are shown as
enrichment values (bound/input)
relative to immunoprecipitation
with IgG antibody and are
means   SD of 2–3 independent
ChIP experiments. *, p < .05,
**, p < .03, ***, p < .01.
2160 Gﬁ-1B Stays Active upon Erythroid DifferentiationThe process of gene repression during development often
involves changes in chromatin structure and histone modiﬁca-
tions that mimic heterochromatin [25]. Recently, it has been pro-
posed that Gﬁ proteins could participate in a multistep process
thatleadstotherecruitmentofthechromatinregulatoryproteins,
HDAC, CoREST, and LSD1 followed by heterochromatization
and gene silencing [17]. However, our data show that this does
not apply to the Gﬁ-1B promoter at erythroblast stages. Indeed,
while Gﬁ-1 (in immature progenitors) or Gﬁ-1B (in differenti-
ated cells) are bound to the Gﬁ-1B promoter, active chromatin
marks are maintained at this promoter from multipotent progeni-
tors to differentiated cells. These active chromatin marks, acety-
lation and methylation on K4 of histone H3, increase at the Gﬁ-
1B promoter during erythroid development. These results were
obtained in differentiated erythroid cells from human CD34
immature progenitors. The same active marks were also found at
the Gﬁ-1B promoter in K562 cells induced to differentiate in the
presence of AraC (supporting information Fig. 3B–E). Our
results show that this increase in histone H3 acetylation is due to
the lackof HDAC recruitment attheGﬁ-1B promoterthroughout
the erythroid differentiation. Histone H3 hyperacetylation due
to the absence of HDAC would then lead to the subsequent
release of LSD1 and CoREST corepressors. These ﬁndings are
in agreement with published results indicating that an hypoace-
tylated histones are better substrates for the LSD1/CoREST
complex than hyperacetylated histones [22]. By contrast, HDAC
is recruited to the c-myc promoter, at erythroblast stages, leading
to histone H3 hypoacetylation, recruitment of LSD1 and
CoREST, andc-myc transcription repression.
The reasons why HDAC is recruited to the c-myc but not
to the Gﬁ-1B promoter are not clear at this stage. The amount
of GATA-1 and/or Gﬁ-1B bound to the promoter sequence
might determine HDAC recruitment and/or stability of the
complexes [26]. Indeed, DNA precipitation experiments with
oligonucleotides corresponding to the Gﬁ-1B or c-myc pro-
moters indicate that although the same quantity of GATA-1
bind to both oligonucleotides, less Gﬁ-1B is found on the c-
myc promoter sequence as compared to that of Gﬁ-1B. Equiva-
lent results were obtained by ChIP experiments. Alternatively,
additional factors recruited to the c-myc and Gﬁ-1B promoters
might induce or not HDAC recruitment. Several examples of
such cooperation between nuclear proteins in chromatin
remodeling process have been described. For example, the co-
factor Fog is required at the Kit promoter for induction of tran-
sition in chromatin conformations by the switch GATA-2/
GATA-1 and subsequent inhibition of transcription [23],
BHC80 is necessary for the association of LSD1 with unme-
thylated K4 of H3 histone [27], and ZNF198 stabilizes the
LSD1/CoREST/HDAC complex on chromatin [28].
Accumulating evidences indicate that when a stem cell is
committed to differentiate towards a speciﬁc lineage, global
genome reprogramming involves both repression of nonafﬁli-
ated genes and selective activation of genes involved in this
lineage. The Gﬁ-1B gene follows an epigenetic program cor-
responding to an erythroid-afﬁliated gene [29]: in immature
progenitors, Gﬁ-1B promoter exhibits active chromatin marks
such as dimethylation on K4 of histone H3; Gﬁ-1B locus is
thus in a pre-activated state. Then, Gﬁ-1B transcription is
maintained throughout erythroid differentiation, these epige-
netic marks remaining on its promoter.
In conclusion, we show here that Gﬁ-1B is preactivated in
immature progenitors and then activated throughout erythroid
differentiation. The loss of the repressive function of Gﬁ-1B
on its own promoter results from the absence of HDAC
recruitment, the hyperacetylation of histone H3, and subse-
quent release of chromatin modifying enzymes responsible for
stable silencing. This difference in the HDAC recruitment
Figure 6. LSD1 and CoREST bind to c-myc but not to Gﬁ-1B oli-
gonucleotides. (A): Gﬁ and GATA protein expression during ery-
throid differentiation of UT-7 5.3 cells. UT-7 5.3 cells cultured in the
presence of granulocyte-macrophage colony-stimulating factor were
induced to differentiate in the presence of erythropoietin (EPO). Cells
were lysed the ﬁrst day (E0) and 5 days (E5) after induction of ery-
throid differentiation by EPO. The nuclear cell lysates were analyzed
by Western blot with Gﬁ-1, Gﬁ-1B, GATA-1 and GATA-2 speciﬁc
antibodies. Actin was detected by a speciﬁc antibody to conﬁrm equal
protein loading. Cells were stained with benzidine to reveal hemoglo-
bin and the percentage of benzidine positive cells was determined.
(B): Binding of GATA and Gﬁ proteins with Gﬁ-1B promoter oligo-
nucleotides before and after erythroid differentiation. DNA afﬁnity
precipitation experiment with biotinylated oligonucleotides represent-
ing the Gﬁ-1B promoter was performed using nuclear extracts from
UT-7 5.3 cells cultured in the presence of GM-CSF (E0) or stimu-
lated by EPO during 5 days (E5). Then 4 lg of wild-type (1) or
mutated (2) biotin-labeled oligonucleotides representing the Gﬁ-1B
core of the Gﬁ-1B promoter (-69 to –37 from the start site) were
used. The three Gﬁ-1/Gﬁ-1B binding sites in the Gﬁ-1B core oligonu-
cleotide were mutated into GGTC. Proteins bound to the DNA tem-
plate were analyzed by SDS-polyacrylamide gel electrophoresis
(PAGE) and Western blotting using antibodies as indicated. (C):
Comparison of GATA-1, Gﬁ-1B, LSD1, and CoREST binding with
Gﬁ-1B and c-myc oligonucleotides. DNA-binding afﬁnity precipita-
tion experiment was performed with biotinylated-oligonucleotides rep-
resenting Gﬁ-1B (Gﬁ-1B core as above) or c-myc promoter (sequence
from -868 to -840 of c-myc gene). UT-7 cells were induced to differ-
entiate and lysates were prepared 5 days after induction of differentia-
tion with EPO. Nuclear extracts were incubated with increasing
quantities of oligonucleotides (from 1–4 lg indicated by black
wedges) of wild-type or with 4 lg of mutated (indicated by a cross)
oligonucleotides, precipitated with streptavidin beads and analyzed by
Western blotting using antibodies against Gﬁ-1B or GATA-1, LSD1
and CoREST. This experiment is representative of three experiments.
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www.StemCells.comcould be at the origin of the difference in the regulation of
the transcription of Gﬁ-1B and of its target genes.
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